CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$56.00 +1.91 (+3.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Non-Current Assets (2015 - 2026)

Updated

CRISPR Therapeutics AG's Non-Current Assets was $279 million in Q2 2026, down 5.8% from $296.05 million a year earlier but up 0.6% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Non-Current Assets (2015 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at CRISPR Therapeutics AG came in at $279.57 million, down 8.3% from FY2024.

  • Non-Current Assets has now declined for three consecutive years, though with a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
  • In earlier years, Non-Current Assets was $304.9 million in FY2024 (-5.2%), $321.49 million in FY2023 (-17.6%), $390.03 million in FY2022 (+16.6%) and $334.36 million in FY2021 (+200.3%).
  • Quarterly Non-Current Assets has moved between $277.46 million (Q1 2026) and $420.65 million (Q3 2022) over five years.
  • Compared with a year earlier, Non-Current Assets has declined for three straight quarters, with an average decline of 5.7% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Assets over five years was Q3 2021 (growth of 221.8%); the worst was Q3 2023 (a decline of 22.4%).
  • Per Business Quant data, CRSP's Non-Current Assets in the three quarters before Q2 2026 was $277.46 million (Q1 2026), $279.57 million (Q4 2025) and $316.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 CRISPR Therapeutics AG 5.23 Bn 5.23 Bn - 279.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 279.00 Mn
Mar 31, 2026 277.46 Mn
Dec 31, 2025 279.57 Mn
Sep 30, 2025 316.22 Mn
Jun 30, 2025 296.05 Mn
Mar 31, 2025 298.49 Mn
Dec 31, 2024 304.90 Mn
Sep 30, 2024 312.24 Mn
Jun 30, 2024 329.45 Mn
Mar 31, 2024 319.39 Mn
Dec 31, 2023 321.49 Mn
Sep 30, 2023 326.24 Mn
Jun 30, 2023 337.44 Mn
Mar 31, 2023 336.40 Mn
Dec 31, 2022 390.03 Mn
Sep 30, 2022 420.65 Mn
Jun 30, 2022 356.31 Mn
Mar 31, 2022 345.56 Mn
Dec 31, 2021 334.36 Mn
Sep 30, 2021 302.79 Mn
API Access

CRISPR Therapeutics AG Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=CRSP&period=max&api_key=YOUR_API_KEY